Keywords: Cancer Research UK, Aura Biosciences, USA, KLicensing, Cancer-targeting peptides

CRT grants rights for targeting technology to Aura

Article | 24 December 2009

Cancer Research Technology (CRT), Cancer Research UK’s commercialization and development arm, has granted Cambridge, Massachusetts, USA-based Aura Biosciences a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Alpha

Prolastin

Go to drug listing